| Literature DB >> 8345601 |
Abstract
On the basis of reports describing nitric oxide as a form of endothelium-derived relaxing factor and on our own experience with intracavernous use of nitric oxide-releasing substances in animal models, we undertook an approved human study of intracavernous sodium nitroprusside as a treatment for impotence. We report our early experience in which severe hypotension and only mild tumescence in our first 3 patients caused us to discontinue the trial.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8345601 DOI： 10.1016/s0022-5347(17)35634-3
Source DB: PubMed Journal: J Urol ISSN： 0022-5347 Impact factor: 7.450